Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Exxon Mobil
XOM
|
$267M |
| 2 |
Chevron
CVX
|
$202M |
| 3 |
Tesla
TSLA
|
$201M |
| 4 |
NVIDIA
NVDA
|
$182M |
| 5 |
Pfizer
PFE
|
$123M |
Top Sells
| 1 |
Apple
AAPL
|
$270M |
| 2 |
First Solar
FSLR
|
$147M |
| 3 |
Walmart
WMT
|
$138M |
| 4 |
Steel Dynamics
STLD
|
$123M |
| 5 |
Reliance Steel & Aluminium
RS
|
$117M |
Sector Composition
| 1 | Technology | 17.96% |
| 2 | Financials | 15.55% |
| 3 | Industrials | 13.45% |
| 4 | Consumer Discretionary | 11.05% |
| 5 | Healthcare | 10.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Immunome
IMNM
$916M
| $122K | ﹤0.01% |
15,433
| – | – |
|
3302
Erasca
ERAS
$457M
| $120K | ﹤0.01% |
43,372
-37,004
| -46% | -$102K |
|
3303
Nkarta
NKTX
$161M
| $115K | ﹤0.01% |
52,681
+13,922
| +36% | +$30.5K |
|
3304
Capricor Therapeutics
CAPR
$308M
| $115K | ﹤0.01% |
24,085
-74,112
| -75% | -$354K |
|
3305
McEwen Inc.
MUX
$734M
| $115K | ﹤0.01% |
15,954
| – | – |
|
3306
Cardlytics
CDLX
$49.6M
| $114K | ﹤0.01% |
+18,016
| New | +$114K |
|
3307
Montauk Renewables
MNTK
$294M
| $113K | ﹤0.01% |
+15,227
| New | +$113K |
|
|
IRD
3308
Opus Genetics, Inc. Common Stock
IRD
$76.1M
| $111K | ﹤0.01% |
25,592
| – | – |
|
|
CZOO
3309
DELISTED
Cazoo Group Ltd
CZOO
| $109K | ﹤0.01% |
918
-6
| -0.6% | -$711 |
|
|
IMAB
3310
I-MAB
IMAB
$358M
| $108K | ﹤0.01% |
36,123
-7,790
| -18% | -$23.3K |
|
3311
X4 Pharmaceuticals
XFOR
$78.6M
| $107K | ﹤0.01% |
1,843
-134
| -7% | -$7.8K |
|
3312
Soleno Therapeutics
SLNO
$3.71B
| $107K | ﹤0.01% |
24,966
-5,173
| -17% | -$22.2K |
|
3313
Q32 Bio
QTTB
$20.4M
| $106K | ﹤0.01% |
6,679
-862
| -11% | -$13.7K |
|
3314
Alpha Teknova
TKNO
$233M
| $106K | ﹤0.01% |
39,740
-10,200
| -20% | -$27.2K |
|
3315
Aspen Aerogels
ASPN
$544M
| $105K | ﹤0.01% |
13,362
-117,443
| -90% | -$927K |
|
3316
Standard BioTools
LAB
$497M
| $105K | ﹤0.01% |
54,398
-28,215
| -34% | -$54.5K |
|
3317
American Coastal Insurance
ACIC
$554M
| $105K | ﹤0.01% |
23,516
| – | – |
|
3318
Turkcell
TKC
$4.83B
| $103K | ﹤0.01% |
28,927
+1,080
| +4% | +$3.86K |
|
3319
Clover Health Investments
CLOV
$1.41B
| $103K | ﹤0.01% |
114,259
-8,480
| -7% | -$7.61K |
|
|
PPTA
3320
Perpetua Resources
PPTA
$1.98B
| $102K | ﹤0.01% |
27,910
| – | – |
|
3321
Beyond Air
XAIR
$11.5M
| $101K | ﹤0.01% |
1,182
+452
| +62% | +$38.5K |
|
|
ICVX
3322
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $100K | ﹤0.01% |
+10,109
| New | +$100K |
|
3323
QuickLogic
QUIK
$84.4M
| $99.6K | ﹤0.01% |
10,842
| – | – |
|
3324
Nortech Systems
NSYS
$25.9M
| $99.2K | ﹤0.01% |
10,138
| – | – |
|
|
SALM
3325
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
| $98.8K | ﹤0.01% |
103,131
-17,615
| -15% | -$16.9K |
|